Alain Micaleff

Merck Serono (Switzerland) — Switzerland

Economics, Econometrics and Finance · Social Sciences

9h-index615citations19works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(14), Meta-analysis and systematic reviews(5), Pharmaceutical Economics and Policy(4), Statistical Methods in Clinical Trials(3), Health Policy Implementation Science(2)

Publications19 total

Pragmatic Multicriteria Decision Analysis (MCDA) Combined With Advanced Pharmacoepidemiology for Benefit-Risk Assessments of Medicines Adapted to the Real-Life Constraints of Regulators: Development and Case Study
Therapeutic Innovation & Regulatory Science·2016· 8 cited
Recommendations for benefit–risk assessment methodologies and visual representations
Pharmacoepidemiology and Drug Safety·2016· 65 citedOpen Access
Recommendations for benefit–risk assessment methodologies and visual representations
London School of Economics and Political Science Research Online (London School of Economics and Political Science)·2016· 1 cited
Literature review of visual representation of the results of benefit–risk assessments of medicinal products
Pharmacoepidemiology and Drug Safety·2015· 32 citedOpen Access
Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions
Clinical Pharmacology & Therapeutics·2015· 45 cited
Combining Mcda With Advanced Statistics To Tackle Challenges Of Data And Judgment Uncertainty: Case Study Of Safety Assessments
Value in Health·2015
Literature review of visual representation of the results of benefit–risk assessments of medicinal products
London School of Economics and Political Science Research Online (London School of Economics and Political Science)·2015Open Access
Benefit–risk assessment in a post‐market setting: a case study integrating real‐life experience into benefit–risk methodology
Pharmacoepidemiology and Drug Safety·2014· 21 cited
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies
Pharmacoepidemiology and Drug Safety·2014· 116 cited
Pragmatic Mcda Combined With Advanced Pharmacoepidemiology For Quantitative Benefit/Risk Assessments Of Medicines
Value in Health·2014Open Access
IMI-PROTECT benefit-risk grouprecommendations report:recommendations for the methodology andvisualisation techniques to be used in theassessment of benefit and risk of medicines
London School of Economics and Political Science Research Online (London School of Economics and Political Science)·2014· 15 cited
Review of visualisation methods for therepresentation of benefit-risk assessment ofmedication: stage 2 of 2
London School of Economics and Political Science Research Online (London School of Economics and Political Science)·2013· 5 cited
IMI work package 5: report 2:b:ii benefit - riskwave 2 case study report: Rosiglitazone
London School of Economics and Political Science Research Online (London School of Economics and Political Science)·2013· 2 cited
IMI work package 5: report 1:b:iii benefit - riskwave 1 case study report:Raptiva® (efalizumab)
London School of Economics and Political Science Research Online (London School of Economics and Political Science)·2013· 4 cited
Weighing benefit–risk of medicines: concepts and approaches
Drug Discovery Today Technologies·2011· 9 cited
Hepatic Reactions During Treatment of Multiple Sclerosis with Interferon-??-1a
Drug Safety·2003· 96 cited
[Good practices of publication of clinical cases of pharmacovigilance: comments, Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentary].
PubMed·1997· 7 cited
Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.
Gut·1992· 189 citedOpen Access
[Amoxicillin as a 1st choice: 275 acute focal pneumopathies treated on an outpatient basis].
PubMed·1990

Frequent Co-authors

Shahrul Mt‐Isa(10), Deborah Ashby(10), Lawrence D. Phillips(9), Christine E. Hallgreen(8), Kimberley Hockley(6), Diana Hughes(6), A Lieftucht(6), Ioanna Tzoulaki(5), Gerald Downey(5), Rebecca Noel(5), Georgy Genov(4), Ed Waddingham(4), Edmond S. Chan(4), Juhaeri Juhaeri(4), Alex Asiimwe(4), Richard Hermann(4), Billy Amzal(4), Alesia Goginsky(3), Ruth Peters(3), Mireille Goetghebeur(3)